Co-occurring depressive and substance use disorders in adolescents: An examination of reward responsiveness during treatment

Journal of Psychotherapy Integration

Volumn 24, Issue 2, 2014, Pages 109-121

  Boger, Kathryn D ^a   Auerbach, Randy P ^a   Pechtel, Pia ^a   Busch, Alisa B ^a   Greenfield, Shelly F ^a   Pizzagalli, Diego A ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Adolescent; Depressive disorders; Reward responsiveness; Substance abuse

Indexed keywords

NORADRENALIN UPTAKE INHIBITOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; ALCOHOL CONSUMPTION; ANHEDONIA; ANXIETY; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHILD PSYCHIATRY; CLINICAL ARTICLE; COGNITIVE THERAPY; DEPRESSION; DRUG USE; FAMILY THERAPY; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; MALE; MOTIVATION; MOTIVATIONAL INTERVIEWING; MULTIDIMENSIONAL ANXIETY SCALE FOR CHILDREN; OUTCOME ASSESSMENT; PSYCHOEDUCATION; PSYCHOLOGIC TEST; REINFORCEMENT; RESIDENTIAL CARE; REWARD; REWARD RESPONSIVENESS; SELF REPORT; SEX DIFFERENCE; SHORT COURSE THERAPY; SNAITH HAMILTON PLEASURE SCALE; STAGES OF CHANGE READINESS AND TREATMENT EAGERNESS PERSONAL DRUG USE AND PERSONAL DRINKING QUESTIONNAIRES; SUBSTANCE ABUSE;

EID: 84902075627     PISSN: 10530479     EISSN: 15733696     Source Type: Journal    
DOI: 10.1037/a0036975     Document Type: Article

References (42)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: American Psychiatric Association
2. Bovasso, G. B. (2001). Cannabis abuse as a risk factor for depressive symptoms. The American Journal of Psychiatry, 158, 2033-2037.
3. Cohen, P., Cohen, J., Kasen, S., Velez, C. N., Hartmark, C., Johnson, J.,. .. Streuning, E. L. (1993). An epidemiological study of disorders in late childhood and adolescence-I. Age-and genderspecific prevalence. Journal of Child Psychology and Psychiatry, 34, 851-867.
4. Depp, C., & Lebowitz, B. D. (2007). Clinical trials: Bridging the gap between efficacy and effectiveness. International Review of Psychiatry, 19, 531- 539.
5. Dodge, R., Sindelar, J., & Sinha, R. (2005). The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment. Journal of Substance Abuse Treatment, 28, 189- 196.
6. Forbes, E. E., Shaw, D. S., & Dahl, R. E. (2007). Alterations in reward-related decision making in boys with recent and future depression. Biological Psychiatry, 61, 633-639.
7. Gawin, F. H., & Ellinwood, E. H. (1988). Cocaine and other stimulants: Actions, abuse and treatment. The New England Journal of Medicine, 318, 1173- 1182.
8. Grella, C. E., Hser, Y., Joshi, V., & Rounds-Bryant, J. (2001). Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. Journal of Nervous and Mental Disease, 189, 384 -392.
9. Hankin, B. L., Lakdawalla, Z., Carter, I. L., Abela, J. R. Z., & Adams, P. (2007). Are neuroticism, cognitive vulnerabilities and self-esteem overlapping or distinct risks for depression? Evidence from exploratory and confirmatory factor analyses. Journal of Social and Clinical Psychology, 26, 29-63.
10. Harrington, R., Fudge, H., Rutter, M., Pickles, A., & Hill, J. (1990). Adult outcomes of child and adolescent depression. I. Psychiatric status. Archives of General Psychiatry, 47, 465-473.
11. Hatzigiakoumis, D. S., Martinotti, G., Giannantonio, M. D., & Janiri, L. (2011). Anhedonia and substance dependence: Clinical correlates and treatment options. Frontiers in Psychiatry, 2, 1-12.
12. Hautus, M. J. (1995). Corrections for extreme proportions and their biasing effects on estimated values of d=. Behavior Research Methods, Instruments & Computers, 27, 46 -51.
13. Heinz, A., Schmidt, L. G., & Reischies, F. M. (1994). Anhedonia in schizophrenic, depressed, or alcohol-dependent patients. Pharmacopsychiatry, 27, 7-10.
14. Henriques, J. B., Glowacki, J. M., & Davidson, R. J. (1994). Reward fails to alter response bias in depression. Journal of Abnormal Psychology, 103, 460-466.
15. Kandel, D. B., Johnson, J. G., Bird, H. R., Weissman, M. M., Goodman, S. H., Lahey, B. B.,. .. Schwab-Stone, M. E. (1999). Comorbidity among adolescents with substance use disorders: Findings from the MECA study. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 693- 699.
16. Kessler, R. C., Avenevoli, S., & Merikangas, K. R. (2001). Mood disorders in children and adolescents: An epidemiological perspective. Biological Psychiatry, 49, 1002-1014.
17. Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S.,. .. Kendler, K. S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the national comorbidity survey. Archives of General Psychiatry, 51, 8-19.
18. Leshner, A. I. (1999). Science based views of drug addiction and its treatment. The Journal of the American Medical Association, 282, 1314-1316.
19. Loas, G. (1996). Vulnerability to depression: A model centered on anhedonia. Journal of Affective Disorders, 41, 39 -53.
20. Macmillian, N. A., & Creelman, C. D. (2005). Detection theory: A user's guide, 2nd ed. Mahwah, NJ: Erlbaum, Inc.
21. March, J. S., Sullivan, K., & Parker, J. (1999). Testretest reliability of the Multidimensional Anxiety Scale for Children. Journal of Anxiety Disorders, 13, 349 -358.
22. McCabe, C., Mishor, Z., Cowen, P. J., & Harmer, C. J. (2010). Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biological Psychiatry, 67, 439 - 445.
23. McMakin, D. L., Olin, T. M., Porta, G., Dietz, L. J., Emslie, G., Clarke, G.,. .. Brent, D. A. (2012). Anhedonia predicts poorer recovery amount youth with selective serotonin reuptake inhibitor treat-ment-resistant depression. Journal of the American Academy of Child and Adolescent Psychiatry, 51, 404-411.
24. Miller, N. S., Summers, G. L., & Gold, M. S. (1993). Cocaine dependence: Alcohol and other drug dependence and withdrawal characteristics. Journal of Addictive Diseases, 12, 25-35.
25. Miller, W. R., & Tonigan, J. S. (1996). Assessing drinkers' motivations for change: The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). Journal of Psychology of Addictive Behaviors, 10, 81-89.
26. Pizzagalli, D. A., Holmes, A. J., Dillon, D. G., Goetz, E. L., Birk, J. L., Bogdan, R.,. .. Fava, M. (2009). Reduced caudate and nucleus accumbens response to rewards in unmedicated subjects with Major Depressive Disorder. The American Journal of Psychiatry, 166, 702-710.
27. Pizzagalli, D. A., Iosifescu, D., Hallett, L. A., Ratner, K. G., & Fava, M. (2008). Reduced hedonic capacity in major depressive disorder: Evidence from a probalistic reward task. Journal of Psychiatric Research, 43, 76 - 87.
28. Pizzagalli, D. A., Jahn, A. L., & O'Shea, J. P. (2005). Toward an objective characterization of an anhedonic phenotype: A signal-detection approach. Biological Psychiatry, 57, 319-327.
29. Radloff, L. S. (1977). The CES-D Scale: A selfreport depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
30. Santesso, D. L., Dillon, D. G., Birk, J. L., Holmes, A. J., Goetz, E., Bogdan, R., & Pizzagalli, D. A. (2008). Individual differences in reinforcement learning: Behavioral, electrophysiological, and neuroimaging correlates. NeuroImage, 42, 807- 816.
31. Siegle, G., Carter, C., & Thase, M. (2006). Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. The American Journal of Psychiatry, 163, 735-738.
32. Silberman, M. A., & Snarey, J. (1993). Gender differences in moral development during early adolescence: The contribution of sex-related variations in maturation. Current Psychology, 12, 163-171.
33. Snaith, R. P., Hamilton, M., Morley, S., Humayan, A., Hargreaves, D.,&Trigwell, P. (1995). A scale for the assessment of hedonic tone: The Snaith-Hamilton Pleasure Scale. The British Journal of Psychiatry, 167, 99-103.
34. Swendsen, J., Burstein, M., Case, B., Conway, K. P., Dierker, L., He, J., & Merikangas, K. R. (2012). Use and abuse of alcohol and illicit drugs in US adolescents: Results of the National Comorbidity Survey-Adolescent Suppl. Archives of General Psychiatry, 69, 390-398.
35. Tomlinson, K. L., Brown, S. A., & Abrantes, A. (2004). Psychiatric comorbidity and substance use treatment outcomes of adolescents. Psychology of Addictive Behaviors, 18, 160-169.
36. Tripp, G., & Alsop, B. (1999). Sensitivity to reward frequency in boys with attention deficit hyperactivity disorder. Journal of Clinical Child Psychology, 28, 366 -375.
37. United States Department of Health and Human Services. (2002). Report to Congress on the Prevention & Treatment of Co-occurring Substance Abuse and Mental Disorders. Rockville, MD: Substance Abuse and Mental Health Services Administration.
38. United States Department of Health and Human Services. (2009). National survey on drug use and health. Rockville, MD: Substance Abuse and Mental Health Services Administration.
39. Vrieze, E., Ceccarini, J., Pizzagalli, D. A., Bormans, G., Vandenbulcke, M., Demyttenaere, K.,. .. Claes, S. (2013). Measuring extrastriatal dopamine release during a reward learning task. Human Brain Mapping, 34, 575-586.
40. Vrieze, E., Pizzagalli, D. A., Demyttenaere, K., Hompes, T., Sienaert, P., de Boer, P.,. .. Claes, S. (2012). Reduced reward learning predicts outcome in major depressive disorder. Biological Psychiatry, 73, 639-645.
41. Weiss, A. P., Guidi, J., & Fava, M. (2009). Closing the efficacy-effectiveness gap: Translating both the what and the how from randomized controlled trials to clinical practice. Journal of Clinical Psychiatry, 70, 446-449.
42. Weisz, J. R., Donenberg, G. R., Han, S. S., & Weiss, B. (1995). Bridging the gap between laboratory and clinic in child and adolescent psychotherapy. Journal of Consulting and Clinical Psychology, 63, 688-701.